ArticleThe journal of headache and pain2024

An economic evaluation of eptinezumab for the preventive treatment of migraine in the UK, with consideration for natural history and work productivity.

Edward Griffin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.